The QualityStocks Daily Thursday, September 5th, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(EAST) $1.4400 +89.45%

QualityStocks(HOTH) $1.2600 +77.49%

Broad Street(APLD) $5.3700 +65.74%

The QualityStocks Daily Stock List

LightInTheBox Holding Co. (LITB)

StreetInsider, StockMarketWatch, StockEarnings, TradersPro, Marketbeat.com, All about trends, MarketBeat, StocksEarning, Zacks, QualityStocks, Jason Bond, Hit and Run Candle Sticks, Street Insider, TopPennyStockMovers, Trades Of The Day, Trading Markets, InvestorPlace, FreeRealTime, Early Bird and One Hot Stock reported earlier on LightInTheBox Holding Co. (LITB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LightInTheBox Holding Co. Ltd (NYSE: LITB) (FRA: L4XA) (BMV: LITBN) is an online retail firm that operates as a cross-border e-commerce platform that delivers commodities directly to consumers from manufacturers across the globe.

The firm has its headquarters in Shanghai, the People’s Republic of China and was incorporated in June 2007 by Chit Chau, Jun Liu, Liang Zhang, Xin Wen and Qu Ji Guo. It operates in the consumer discretionary sector, under the retail and wholesale industry, in the e-commerce discretionary sub-industry.

The company operates in Europe as well as in North America but obtains the majority of its revenue from Europe. It operates via the services and others and product sales segments. The former segment is made up of logistics and other value-added services like marketing services which are provided mainly to suppliers and small businesses in China while the latter segment is made up of the sale of products like apparel and other general merchandise, via mobile apps and the company’s websites including www.ezbuy.com, www.miniinthebox.com and www.lightinthebox.com.

The enterprise offers general merchandise products like communication devices, electronics, home gardening products, gadgets and accessories as well as fast fashion, special occasion and customized apparel products. This is in addition to providing warehouse management, general support, administration, marketing, local delivery, customer, research and development and supplier chain management services as well as IT support and mobile app software development services.

The firm is focused on reinvesting the majority of its returns at a high return rate, which has boosted the growth in its earnings. This move may in the long term have a positive effect on its share price, which will encourage more investments into the firm.

LightInTheBox Holding Co. (LITB), closed Thursday's trading session at $2.71, up 2.4187%, on 58,744 volume. The average volume for the last 3 months is 3.486M and the stock's 52-week low/high is $2.21/$8.82.

Hoth Therapeutics (HOTH)

QualityStocks, StreetInsider, StockMarketWatch, RedChip, PennyStockProphet, Broad Street, MarketClub Analysis, OTCtipReporter, Penny Pick Finders, PennyStockLocks, StockRockandRoll, Penny Stock 101, OTCBB Journal, BUYINS.NET, HotOTC, StockOnion, MarketBeat, Schaeffer's, INO Market Report, Profitable Trader Authority, Buzz Stocks, PennyStockScholar, StockHideout, Planet Penny Stocks, 247 Market News and TradersPro reported earlier on Hoth Therapeutics (HOTH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hoth Therapeutics Inc. (NASDAQ: HOTH) is a biopharmaceutical firm that is focused on the development of therapies for atopic dermatitis and other ailments such as psoriasis, acne, asthma and chronic wounds.

The firm, which serves consumers in the United States and is based in New York, was founded in May 2017 by James Ahern, Matthew D. Eitner and Robbie Knie.

Hoth Therapeutics is engaged in the development of eczema therapies, having developed its therapeutic platform called BioLexa Platform, which is a patented and drug compound platform for the treatment of eczema. This product is designed to prevent any flare-ups that can trigger eczema symptoms even before they occur. The firm also explores the use of its platform in the aesthetic dermatology field to help reduce and treat post-procedure infections, improve clinical outcomes for individuals undergoing procedures and speed up the healing process.

The company recently entered into 2 separate agreements to develop 2 vaccine prospects for treating and preventing the coronavirus. This is in addition to successfully completing a pre-IND meeting with the FDA for its HT-001 product, which is indicated for the treatment of skin disorders and rashes in cancer patients.

Cancer patients who suffer from various dermatological diseases during epidermal growth factor receptor inhibitor treatment may soon have an answer to their problems, in form of Hoth Therapeutics’ HT-001. With positive feedback from the FDA, the company is not far from approval.

Hoth Therapeutics (HOTH), closed Thursday's trading session at $1.26, up 77.4898%, on 166,377,755 volume. The average volume for the last 3 months is 2.315M and the stock's 52-week low/high is $0.58/$3.37.

Eastside Distilling (EAST)

QualityStocks, TradersPro, MarketBeat, TraderPower, StreetInsider, StockMarketWatch, Trading Concepts and Early Bird reported earlier on Eastside Distilling (EAST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Eastside Distilling, Inc. (NASDAQ: EAST) is engaged in the manufacture, acquisition, blending, bottling, importing, exporting, marketing and selling of various alcoholic beverages.

The company has its headquarters in Portland, Oregon and was incorporated in 2008, on February 11th by Lenny Gotter. It sells its products on a wholesale basis to distributors across the United States.

The firm sells whiskey under the Burnside Whiskey brand, vodka under the Portland Potato Vodka brand name, tequila under the Azunia Tequila brand and rum under the brand name of Hue-Hue Coffee Rum. It first introduced their first series of flavored and fine rums in 2009 and uses products made in the state of Oregon.

The company’s RTD brands include Portland Mule-Marionberry, Portland Mule-Original and Redneck Riviera Howdy Dew while its branded whiskeys include Big Bottom Delta Rye, Burnside Oregon Oaked Rye whiskey and Redneck Riviera whiskey. Its vodka brand includes Portland Potato Vodka-Habanero, Portland Potato Vodka-Marionberry and Portland Potato Vodka while its tequila brands include Azunia Amejo Tequila and Azunia Blanco Organic Tequila. The company also has rum and gin brands, which are made up of Hue-Hue Coffee Rum and Big Bottom London Dry Gin, Big Bottom Barrel Finished Gin and Big Bottom Navy Strength, respectively.

The enterprise recently closed a private placement offering with District 2 Capital Fund LP and Bigger Capital Fund LP. This move will improve the company’s liquidity position and help in the advancement of their growth and expansion objectives, which will help bring in more investors.

Eastside Distilling (EAST), closed Thursday's trading session at $1.44, up 89.4485%, on 137,750,303 volume. The average volume for the last 3 months is 53,153 and the stock's 52-week low/high is $0.65/$2.98.

Probe Gold (PROBF)

QualityStocks, MarketBeat and InvestorPlace reported earlier on Probe Gold (PROBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Probe Gold Inc. (OTCQB: PROBF) (TSE: PRB) (FRA: V46) is a gold exploration firm that is focused on acquiring, exploring and developing gold properties in Canada.

The firm has its headquarters in Toronto, Canada and was incorporated in 2015, on January 16th. Prior to its name change in January 2023, the firm was known as Probe Metals Inc. It operates as part of the gold industry, under the basic materials sector. The firm mainly serves consumers in Canada.

The company is committed to discovering and developing high-quality gold projects, which include its flagship asset, the multimillion-ounce Novador Gold Project. This project comprises of roughly 436 km2 and is located in the city of Val-d'Or, in the province of Québec. The company’s other projects include the Dubuisson property, which is located in Dubuisson Township, over 7 km west of downtown Val-d’Or. The Detour Quebec project covers an area of 777 km2 along the Detour Gold trend and is located over 190 km north of Rouyn-Noranda and 40 km northwest of the town of Matagami, Quebec. The company’s Casa Cameron Project is in the north of La Sarre, Amos and Lebel-sur-Quevillon, in the northwest region of the province of Quebec. The Timmins West project is located in the western part of the prolific Timmins gold camp, approximately 19 km west of the town of Timmins.

The enterprise remains focused on advancing its Novador Gold Project, which is one of Canada’s largest and most advanced gold exploration projects in development. The project’s success will generate significant value for its shareholders.

Probe Gold (PROBF), closed Thursday's trading session at $1.095, up 18.0529%, on 145,669 volume. The average volume for the last 3 months is 8.521M and the stock's 52-week low/high is $0.7132/$1.23.

Sunhydrogen Inc. (HYSR)

QualityStocks, Investor News Source, OTCPicks, Beacon Equity Research, InvestorPlace, Stock Preacher, StockHideout, PennyTrader Publisher, InvestorSoup, MicroStockProfit, Penny Stocks Finder, Wallstreetlivechat, InvestorIntel, Stock Roach, TheLightningPicks, SmallCapStockPlays, OTCReporter, Investors Online Bell, Top Stock Picks, MarketClub Analysis, Hotstocked, PennyStockRumors.net, Wise Alerts, Penny Stock Finder, FeedBlitz, HotPennyInvest.com, HotOTCChina.com, Crazy Carl, CrushTheStreet.com, HotOTCBuzz.com, Greenbackers, HotOTCPicks.com, JumpingPennyStocks.com, LightningStockPicks, Nebula Stocks, AimHighProfits, OTCPennyPicks.com, Penny Stock Craze, Pumps and Dumps, Real Pennies, SmartPennyInvest.com, Stockpalooza, TheMicrocapNews, TopPennyStockMovers and OTCNewsAlerts.com reported earlier on Sunhydrogen Inc. (HYSR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sunhydrogen Inc. (OTC: HYSR) is focused on generation and marketing of renewable energy and is engaged in the provision of renewable energy services.

The company is based in Santa Barbara, California and incorporated in 2009, on February 18th. It serves consumers in the state of California. Prior to its name change, the firm was known as Hypersolar Inc.

SunHydrogen caters to metal processing, ammonia production, refineries and other sectors and produces economical renewable hydrogen using sunlight. It has developed a nanoparticle system that’s solar-powered and imitates photosynthesis to separate hydrogen from water. It plans to get this system’s technology to be licensed, allowing it to be used in producing renewable hydrogen and electricity for fuel cells. It generates energy from sunlight.

Its technology, the HyperSolar H2Generator, is used to develop a submersible hydrogen production particle which splits H2O molecules under the sun. Every particle is a complete hydrogen generator and contains a high voltage solar cell that’s bonded to chemical catalysts via an encapsulation coating. It is also developing a modular system that will allow for the daily production and storage of hydrogen that can be used at any time in the manufacture of fertilizer, oil and gas refining, the generation of electricity and any other hydrogen applications.

The company recently appointed a new Board Director and Chief Operating Officer, who has under his belt years of experience and is known for his strategic approach and leadership in operations management. This move will aid in the expansion of the firm’s brand footprint and global relationships, which will bring in investments.

Sunhydrogen Inc. (HYSR), closed Thursday's trading session at $0.024625, up 15.6103%, on 27,602,166 volume. The average volume for the last 3 months is 21,096 and the stock's 52-week low/high is $0.01/$0.026.

Recruiter.com Group, Inc. (RCRT)

RedChip, QualityStocks, TradersPro, Red Chip, MarketClub Analysis, The Stock Dork, The Online Investor, PennyStockScholar, PennyStockProphet, MarketBeat, Emerging Markets and 360 Wall Street reported earlier on Recruiter.com Group, Inc. (RCRT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Recruiter.com Group, Inc. is a leading platform connecting recruiters and employers. An expert network for recruiters, the Company pairs enterprises with an extensive network of recruiters and powerful AI (Artificial Intelligence) matching tools to foster the hiring of premier talent faster and smarter. Recruiter.com provides recruiters SHRM certified recruitment training and independent earning opportunity. It provides enterprise and mid-market employers recruiting services designed to scale across a varied range of skills and industries.

Recruiter.com Group is headquartered in Houston, Texas. The Company also has additional offices in Bristol, Connecticut, and Ebene, Mauritius. Recruiter.com Group lists on the OTC Markets Group’s OTCQB.

The Company has strategic partnerships in manifold areas of the recruitment process. These include AI candidate matching software, applicant tracking systems, job sites, resume writing and career services, recruitment and career content providers, and recruitment service and outsourcing firms.

The design of Recruiter.com’s business is to accelerate recruiting and hiring success by way of technology adoption. The Company’s chief product and service is its cloud-based “Job Market” software platform for professional hiring. The Job Market software facilitates connections to a nationwide network of professional recruiters.

Furthermore, the Job Market software is augmented by proprietary AI technologies that draw from talent communities of millions of people. Recruiter.com provides employers a flexible, performance-based hiring model for permanent and contract talent.

Recruiter.com Group has a strategic partnership agreement with Censia, Inc. Censia is the operator of a worldwide talent intelligence platform with half a billion of the world’s professionals, indexed and analyzed through AI. This partnership with Censia enables Recruiter.com’s network of independent recruiters and internal Talent Delivery team access to Censia on a performance basis.

Recruiter.com Group, Inc. (RCRT), closed Thursday's trading session at $2.13, up 12.6984%, on 71,236 volume. The average volume for the last 3 months is 93,898 and the stock's 52-week low/high is $1.0442/$2.58.

DIH Holding (DHAI)

360 Wall Street reported earlier on DIH Holding (DHAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DIH Holding US Inc. (NASDAQ: DHAI) (NASDAQ: DHAIW) is a robotics and virtual reality technology provider that specializes in offering robotic and virtual reality technologies with clinical integration and insights to improve the functioning of people with disabilities and functional impairments.

The firm has its headquarters in Norwell, Massachusetts and was incorporated in 2007 by Jason Chen. It operates as part of the medical devices industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on consumers in the Middle East, Europe, Africa, the Asia Pacific, and the United States.

The enterprise’s offerings include ArmeoSpring for less severe patients, which offers self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; Armeo Senso, for patients’ self-initiated and still structurally controlled movement patterns to completely open movement; and ArmeoSpring Pro. It also offers lower extremity products, including Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; CAREN, a computer assisted rehabilitation environment; Andago, a robotics smart control system that assists patients in walking naturally; GRAIL, an gait real-time analysis interactive lab solution for analysis training and research; and C-Mill, creates a training environment. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software.

The company recently announced its latest financial results, which show increases in its revenues. It remains committed to enriching its product solution offerings, which will positively influence revenues and investments into the company.

DIH Holding (DHAI), closed Thursday's trading session at $2.46, up 6.0345%, on 34,565 volume. The average volume for the last 3 months is 22.734M and the stock's 52-week low/high is $0.718/$13.90.

Snap (SNAP)

Schaeffer's, InvestorPlace, The Street, MarketClub Analysis, MarketBeat, StockEarnings, StocksEarning, Trades Of The Day, Kiplinger Today, Zacks, StreetInsider, Daily Trade Alert, Market Intelligence Center Alert, INO Market Report, The Online Investor, Investopedia, Wealth Insider Alert, CNBC Breaking News, Early Bird, QualityStocks, Barchart, The Street Report, Marketbeat.com, StockMarketWatch, Trading Concepts, StreetAuthority Daily, Profit Confidential, Louis Navellier, Top Pros' Top Picks, Market Intelligence Center, FreeRealTime, AllPennyStocks, Investors Alley, GorillaTrades, Daily Profit, Money Morning, Jon Markman’s Pivotal Point, TopStockAnalysts, Investment House, InvestmentHouse, Uncommon Wisdom, Total Wealth, Cabot Wealth, Trading Tips, 24/7 Trader, The Wealth Report, TipRanks, MarketTamer, Investiv, Investing Daily, Investment U, MarketWatch, Max Wealth, Energy & Resources Digest, Economy & Markets, Dynamic Wealth Report, Rick Saddler, SmallCap Network, StockGuru, Wall Street Window, wyatt research newsletter, Daily Wealth, Epic Stock Picks, Direction Alerts, BUYINS.NET, 360 Wall Street, Premium Stock Alerts, Wealth Week, Wealth Daily, Wall Street Profit Search, Wall Street Daily, Technology Profits Daily, StrategicTechInvestor, StockRockandRoll, Schaeffer’s, Promotion Stock Secrets, newmoneycrew, Prism MarketView, InvestorsObserver Team, Power Profit Trades, PennyStockLocks, Penny Stock 101, Penny Picks, OTC Stock Review, Money and Markets, MarketClub, Jon Markman's Pivotal Point, InvestorsUnderground and ProfitableTrading reported earlier on Snap (SNAP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Snap (NYSE: SNAP), the parent company behind the popular social media platform Snapchat, is taking a significant step towards enhancing user experience by testing a “simplified version of Snapchat.” This initiative, as CEO Evan Spiegel explained in a letter to employees, aims to make the platform more accessible and user-friendly. This move, reported by TechCrunch on Sept. 3, 2024, reflects Snap’s commitment to evolving its service to meet user needs better.

The financial metrics of Snap Inc. reveal a company that is currently navigating through challenges, as indicated by its price-to-earnings (“P/E”) ratio of -12.36. This figure suggests that Snap is trading at a loss, with its market price not justified by its earnings over the last twelve months. Despite these challenges, the company’s efforts to simplify Snapchat could be a strategic move to attract more users and potentially improve its financial health.

Snap’s price-to-sales (“P/S”) ratio of approximately 2.90 and an enterprise value to sales (“EV/Sales”) ratio of 3.54 highlight how investors value the company in relation to its sales. These ratios suggest that investors are willing to pay nearly $2.90 for every dollar of Snap’s sales, indicating a belief in the company’s growth potential despite its current financial performance. The initiative to simplify Snapchat could further enhance this perception by potentially increasing user engagement and, subsequently, sales.

Moreover, the enterprise value to operating cash flow (“EV/OCF”) ratio of 72.08 underscores the market’s optimistic valuation of Snap against its operating cash flow. This optimism, coupled with an earnings yield of -8.09%, reflects investor confidence in Snap’s future profitability, despite its current negative earnings. The development of a simplified Snapchat version could play a crucial role in turning these expectations into reality by making the platform more appealing to a broader audience.

Lastly, Snap’s debt-to-equity (“D/E”) ratio of 1.77 and a current ratio of 3.98 provide insights into the company’s financial structure and liquidity. The D/E ratio indicates a higher level of company debt relative to its equity, which could be a concern. However, the strong current ratio suggests that Snap has a robust ability to cover its short-term liabilities with its short-term assets. This financial stability is essential as the company invests in product development, like the simplified version of Snapchat, to drive future growth.

To view the company’s most recent earnings release, visit https://ibn.fm/LKwrR

About Snap Inc.

Snap is a technology company that believes the camera presents the greatest opportunity to improve the way people live and communicate. The company contributes to human progress by empowering people to express themselves, live in the moment, learn about the world, and have fun together. For more information, visit the company’s website at www.Snap.com.

Snap (SNAP), closed Thursday's trading session at $8.87, up 0.9101251%, on 15,422,885 volume. The average volume for the last 3 months is 3.343M and the stock's 52-week low/high is $8.28/$17.90.

Canopy Growth Corp. (CGC)

InvestorPlace, Schaeffer's, The Street, StocksEarning, MarketClub Analysis, StockEarnings, Trades Of The Day, MarketBeat, Daily Trade Alert, Kiplinger Today, QualityStocks, The Online Investor, Wealth Insider Alert, Streetwise Reports, StreetInsider, CFN Media Group, Market Intelligence Center Alert, Investopedia, Zacks, StreetAuthority Daily, Stock Up Featured, The Wealth Report, Daily Profit, Top Pros' Top Picks, SmallCapVoice, Early Bird, StockMarketWatch, Lebed.biz, Wall Street Grand, SeriousTraders, INO Market Report, Profit Trends, Money Morning, BUYINS.NET, Louis Navellier, Cannabis Financial Network News, CNBC Breaking News, Investors Underground, Inside Trading, Jim Cramer, Outsider Club, StocksToBuyNow, Trading For Keeps, TradersPro, MarketClub, Technology Profits Daily, AllPennyStocks, Beat The Street, Wealth Daily, Cabot Wealth, VectorVest, CannabisNewsWire, Trading Concepts, Timothy Sykes, Profit Confidential, TheTradingReport, Insider Wealth Advice, Investment U, InvestmentHouse, Stock Gumshoe, Investors Alley, Rick Saddler, Raging Bull All Access, 24/7 Trader, Money and Markets and Tim Bohen reported earlier on Canopy Growth Corp. (CGC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Brazil’s most populated state, Sao Paulo, home to more than 44 million residents, made history by being the first to pass legislation granting free access to CBD. The legislative victory was largely driven by Brazilian mothers who spent a decade campaigning tirelessly to access CBD for their ill children.

Combining CBD with other medications has shown promise for lowering seizures in individuals with severe epilepsy.

One of the mothers who led the campaign was Maria Aparecida Carvalho. At the age of 10, her daughter, Clárian, was diagnosed with severe epilepsy, which can lead to life-threatening complications, including the sudden cessation of lung and heart function.

The medications prescribed to Clárian had significant side effects, even requiring near-dialysis treatment due to poisoning. Clárian’s prolonged seizures caused immense fear and sleepless nights for her parents, who took turns watching over her.

The story of Charlotte Figi, a U.S. youngster who suffered from the same illness and went on to become a global representative of the advantages of CBD therapy, motivated Carvalho to seek CBD as an alternative. She told her husband right away, suggesting they look into getting it, even from unofficial sources if needed.

However, a few months later, the neurologist treating Clárian succeeded in smuggling some CBD into the nation by bringing it back from overseas. Eventually, with legal assistance, Carvalho obtained a court permit to cultivate cannabis in her compound, allowing her to produce CBD for her daughter and other patients.

Brazil’s current laws permit marijuana use and its extracts for medical and scientific purposes. However, cultivating it remains illegal, forcing the sector to rely on imported marijuana oil and other raw materials, which significantly drives up costs.

San Paulo state legislator Caio França, a center-leftist, drafted a measure in 2019 that would have allowed families to obtain CBD via the country’s public health system. He lobbied his largely conservative colleagues for three years, gradually winning them over with testimonies from families whose children required CBD for treatment.

The measure passed in 2022 with almost two-thirds approval from the state legislature, and Governor Tarcísio de Freitas, a former member of far-right former President Jair Bolsonaro’s Cabinet, signed it into law in January 2023. Due to his conservative background, de Freitas limited the law’s scope to patients with three rare conditions, including Lennox-Gastaut and Dravet syndromes, based on research showing that CBD was effective for these specific ailments.

For companies that have for long manufactured medical marijuana products, such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED), the stories coming out of Brazil about the ways in which cannabis products are helping mothers to manage the conditions of their ill kids serve as case studies of how cannabinoids can manage symptoms that conventional treatments have been ineffective in combating.

Canopy Growth Corp. (CGC), closed Thursday's trading session at $4.74, off by 2.6694%, on 2,468,753 volume. The average volume for the last 3 months is 1.976M and the stock's 52-week low/high is $2.755/$19.20.

Seelos Therapeutics Inc. (SEEL)

QualityStocks, MarketBeat, StockEarnings, StockMarketWatch, PsychedelicNewsWire, MarketClub Analysis, TradersPro, Schaeffer's, Prism MarketView, BUYINS.NET, Trades Of The Day, The Online Investor, Premium Stock Alerts, INO Market Report and 360 Wall Street reported earlier on Seelos Therapeutics Inc. (SEEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Recently conducted research may have found new approaches to treat alcohol-use disorder. One study determined that administering psilocybin is both effective and safe in decreasing the consumption of alcohol in patients with alcohol-use disorder. This study examined 10 adults with severe alcohol use disorder during the 12-week research period.

For their open-label study, investigators at the University of Copenhagen administered one 25mg psilocybin dose to each participant. They observed that the consumption of alcohol by participants reduced significantly, with most of them consuming fewer drinks and craving alcohol less following the treatment.

In their report, the researchers explained that the participants also reported that their confidence in their ability to avoid alcohol had increased.

Individual analyzes show that at week four, nine of the participants considerably decreased drinks consumed daily, with seven of the participants still reporting considerable reductions in drinks consumed daily at the 12-week mark.

In addition, the investigators observed no consequential changes in measures of trait mindfulness, psychological flexibility, or depressive symptoms. They then noted that their findings aligned with existing data, reinforcing the potential benefits of this therapeutic approach.

The study had some limitations, however, including the lack of blinding or a control group, as well as a small sample. The investigators argued that this prevented any causal conclusions on effectiveness to be made.

Furthermore, selection bias due to high expectations from positive media coverage and self-referral may have partly influenced the observed effects. The investigators noted that this highlighted the need for larger, placebo-controlled, single-dose trials to establish firm conclusions.

The research, coauthored by NIDA director, Nora Volkow was reported online at Research Square.

A separate study concluded that classic psychedelics such as LSD and psilocybin had shown potential in treating drug addiction, particularly alcohol-use disorder. For their study, researchers at the University of Southern Sata Catarina conducted an analysis of prior studies into classic psychedelics, concluding that the drugs had shown potential in the treatment of drug addiction.

In their report, the scientists stated that the substances worked mainly be modulating neuroplasticity in the brain, noting that serotonergic psychedelics needed to be considered as treatment options to manage drug-use disorders because they didn’t produce withdrawal symptoms or physical dependence with repeated use.

The researchers did caution that psychedelic-assisted therapies weren’t effective for all patients. They also highlighted the need for further research using experimental protocols and different doses to be carried out to add to evidence on psychedelic drugs.

The researchers published their findings in the “Progress in Neuro-Psychopharmacology and Biological Psychiatry” journal.

Other companies, such as Seelos Therapeutics Inc. (NASDAQ: SEEL), are also conducting their own psychedelic drug development programs with a focus on psilocybin and other hallucinogenic compounds. In time, some of these drug candidates could hit the shelves after going through the regulatory approval process.

Seelos Therapeutics Inc. (SEEL), closed Thursday's trading session at $0.2313, off by 4.6579%, on 395,185 volume. The average volume for the last 3 months is 340,108 and the stock's 52-week low/high is $0.2212/$266.40.

Green Thumb Industries Inc. (GTBIF)

QualityStocks, InvestorPlace, MarketBeat, CannabisNewsWire, Wealth Insider Alert, Cabot Wealth, Trades Of The Day, TradersPro, Daily Trade Alert, The Street, The Online Investor, CFN Media Group, StreetInsider, Zacks, Trading For Keeps, wyatt research newsletter, Prism MarketView, Kiplinger Today, Top Pros' Top Picks, Daily Profit and Technology Profits Daily reported earlier on Green Thumb Industries Inc. (GTBIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last month, Governor Mike Parson of Missouri signed an executive order that would remove all THC drinks and edibles derived from hemp from shelves and impose penalties on any establishment that continued to sell them.

In his statement, Parson stated that the primary target of his order were companies that sold intoxicating hemp edibles mimicking candy. He explained that because hemp wasn’t a controlled substance, there were no federal or state laws prohibiting minors from purchasing these products or even preventing stores from selling the products to underaged individuals.

Last week, the state’s Hemp Trade Association filed a suit in Cole County Circuit Court to stop this ban from taking effect. This comes after the state’s Department of Health and Senior Services issued a memo to food retailers detailing how the ban would be imposed. The association’s attorney, Chuck Hatfield, stated that the memo shed light on what the state wanted to do, noting that it was illegal.

In their argument, leaders in the hemp industry argued that the order banned products which had undergone lab testing, weren’t attractive to minors, and were only sold to consumers aged 21 and above. The order, as per the memo, directs regulators to identify edibles that contain unregulated psychoactive products as adulterated, poisonous and deleterious.

This contradicts the law, which stipulates that food shouldn’t be considered adulterated solely for containing a commodity of industrial hemp or hemp itself. This clause was added to the state’s law after Congress legalized hemp under the 2018 Farm Bill.

Hatfield revealed that in their defense, they would highlight how the department was acting ultra vires by banning psychoactive cannabinoid hemp products across the board. He added that an executive order couldn’t trump Missouri law, particularly when there weren’t administrative rules in place to substantiate their claims.

In other news, emergency rules proposed by the Division of Alcohol and Tobacco Control were rejected by Jay Ashcroft, Missouri’s secretary of state. The rules would  have given the division the authority to enforce the embargo imposed by the U.S. Department of Health and Senior Services (HSS) at premises licensed to sell alcohol or tobacco.

According to state law, HSS regulators will have to visit each individual retailer and place an embargo tag on products deemed adulterated. Hatfield notes the department has no authority to remove things off retailers’ shelves.

Following the rejection, the rules will have to undergo a standard process that may take half a year.

This developing story in Missouri is likely to be of interest to all cannabis companies, including Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), because the proliferation of hemp-derived intoxicants introduces a factor that marijuana industry players have to contend with as they serve their target clients.

Green Thumb Industries Inc. (GTBIF), closed Thursday's trading session at $9.87, up 0.4069176%, on 190,939 volume. The average volume for the last 3 months is 1.417M and the stock's 52-week low/high is $7.57/$16.33.

Momo Inc. (MOMO)

QualityStocks, StocksEarning, MarketClub Analysis, StockEarnings, InvestorPlace, Schaeffer's, Marketbeat, Market Intelligence Center Alert, Zacks, The Street, Trades Of The Day, Kiplinger Today, Daily Trade Alert, StreetInsider, The Street Report, Marketbeat.com, FreeRealTime, BUYINS.NET, The Online Investor, INO.com Market Report, ChineseWire, Trading Concepts, Louis Navellier, TradersPro, Wealth Insider Alert, StreetAuthority Daily, TopStockAnalysts, Money Morning, Investopedia, DividendStocks, Daily Wealth, PennyDoctor, TipRanks, Greenbackers, StockMarketWatch, StocksImpossible, Street Insider, OTCBB Journal, Early Bird, First Penny Picks, ChartAdvisor, Barchart, CrashTrade, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

It seems that Generation Z, a cohort that was born and raised in the information age, is shunning online dating platforms in favor of in-person meet-ups. Local relationship experts say Gen Z’ers are turning away from virtual dating and increasingly prefer to meet potential partners organically, without using technology.

Interestingly, Millennials still prefer to use dating platforms such as Tinder and Hinge, while Gen Z is opting for more traditional means of dating despite being younger and ostensibly more internet savvy. Relationship expert and coach Ntombi Mthembu says there has been an upsurge in in-person interactions among Gen Z’ers as they become more open to meeting people naturally.

Dating apps have made it possible for people who ordinarily wouldn’t have met through friends, family or work to partner up, but they also contributed to a reduction in face-to-face meetups because the apps are more convenient and allow people to access a greater number of potential partners. With the coronavirus pandemic making in-person interaction even more unpopular, the assumption would be that Gen Z would also prefer to find their partners virtually.

However, it seems young people have grown tired of using dating apps and are now in search of deeper connections. Public spaces such as parks and coffee shops in cities are seeing a surge in young people who are meeting and interacting with new acquaintances as Gen Z grows more disillusioned with online dating. A joint experiment between Weekend Witness and several top dating platforms found that Millennials (people aged 28 years of age and older) made up the majority of dating-app users.

According to Mthembu, the findings indicate that most Millennials turned to online dating during the pandemic because it was the only feasible means of meeting new people. They got used to the convenience it offered. Some Millennials prefer to use dating platforms to avoid potential scams and criminal activity as well as to save money.

Online dating can be especially helpful in lowering dating costs because it allows people to get to know each other without having to go out. However, Gen Z is still going out there in increasing numbers to meet new people and find partners in person. Gyms, coffee shops and parks are some of the locations where younger people are finding partners as they eschew online dating.

One Gen Z who met her partner of one and a half years at the gym says meeting people in person feels more authentic. Online dating has also contributed to a culture of disposability where the sheer quantity of potential partners leads to the idea that there could be someone better out there, resulting in a fear of settling down and a lack of commitment.

This emerging trend is likely to be watched closely by entities such as Momo Inc. (NASDAQ: MOMO) for insights pointing to the pain points leading a growing number of people to shun online dating. Addressing those pain points could encourage more people to opt for online dating given its numerous benefits, such as availing a wider pool of potential partners.

Momo Inc. (MOMO), closed Thursday's trading session at $6.42, up 3.5484%, on 1,139,093 volume. The average volume for the last 3 months is 157,535 and the stock's 52-week low/high is $4.79/$8.45.

The QualityStocks Company Corner

TC BioPharm Holdings PLC (NASDAQ: TCBP)

The QualityStocks Daily Newsletter would like to spotlight TC BioPharm Holdings PLC (NASDAQ: TCBP).

5 New patients dosed, bringing total to 6 patients dosed in ACHIEVE at higher dose level

5 Patients received second dose

2 Patients received third dose

BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announces dosing of 5 new patients in the ACHIEVE Phase 2b trial ongoing in the UK.

TC BioPharm Holdings PLC (NASDAQ: TCBP) is a clinical-stage biopharmaceutical company pioneering the development and commercialization of gamma-delta T cell therapies for the treatment of cancer, with a particular focus on acute myeloid leukemia (AML). Gamma-delta T cells are unique immune cells that possess characteristics of both the innate and adaptive immune systems, allowing them to distinguish between healthy and diseased tissues. This dual capability makes them a powerful tool in the fight against cancer, and TC BioPharm is at the forefront of harnessing this potential to develop innovative therapeutics.

As the leader in gamma-delta T cell therapy development, TC BioPharm is the first company to advance to Phase II/pivotal clinical studies in oncology. The company is currently conducting two investigator-initiated clinical trials for its unmodified gamma-delta T cell product line, including a Phase 2b/3 pivotal trial for the treatment of acute myeloid leukemia. This trial utilizes TC BioPharm’s proprietary allogeneic CryoTC technology, which enables the production and distribution of frozen gamma-delta T cell products to clinics worldwide, ensuring broader accessibility and consistency in treatment.

TC BioPharm’s commitment to advancing gamma-delta T cell therapies reflects its broader mission to develop cutting-edge, immune-based treatments that address significant unmet medical needs in oncology. By leveraging the unique properties of gamma-delta T cells, the company aims to revolutionize cancer treatment and improve outcomes for patients with difficult-to-treat cancers like acute myeloid leukemia. With its pioneering approach and robust clinical pipeline, TC BioPharm is well-positioned to become a leader in the field of immuno-oncology.

TCB-008

TC BioPharm’s lead candidate, TCB-008, is an innovative allogeneic gamma-delta T cell therapy currently being evaluated in the ACHIEVE UK clinical trial, a Phase II study targeting patients with acute myeloid leukemia (AML) or myelodysplastic syndromes progressing to AML (MDS/AML). The trial is designed to assess the efficacy and safety of TCB-008 in two distinct patient cohorts: those with relapsed/refractory disease and those in remission but with detectable residual disease. Recently, the trial advanced to a higher dose level, with the sixth patient receiving treatment under the amended protocol, which includes up to 230 million cells per dose—a significant increase from the previous 35 million cells. This dose escalation aligns with the medium dose cohort proposed for the company’s FDA trial in AML, highlighting the company’s commitment to optimizing treatment efficacy.

The ACHIEVE trial represents a critical milestone in TC BioPharm’s development of TCB-008 as a potentially transformative therapy for AML. The ability to advance either cohort independently to a Phase III Pivotal Trial upon meeting primary efficacy endpoints underscores the trial’s flexibility and the potential for rapid progression. With plans to enroll up to 24 patients in each cohort and interim data expected within the next six to nine months, TC BioPharm is likely to achieve key inflection points in 2024. The promising safety and efficacy data generated so far, combined with the company’s strategic efforts to refine and escalate the dose of TCB-008, reinforce the candidate’s potential as a monotherapy and support ongoing discussions for potential combination therapy partnerships.

Market Opportunity

From an investment perspective, TC BioPharm is uniquely positioned within the rapidly expanding field of immuno-oncology, a market projected to grow substantially in the coming years. The company’s focus on gamma-delta T cell therapies, particularly in the treatment of acute myeloid leukemia (AML), sets it apart from competitors in the oncology space. As traditional cancer therapies continue to face challenges in terms of efficacy and patient tolerance, the novel approach of utilizing gamma-delta T cells offers a compelling alternative that could potentially capture significant market share. Investors looking for opportunities in breakthrough cancer therapies may find TC BioPharm’s innovative platform and clinical progress highly attractive.

Additionally, the company’s strategic use of its proprietary CryoTC technology, which facilitates the global distribution of its gamma-delta T cell products, positions TC BioPharm to scale rapidly upon successful clinical outcomes. This technology not only enhances the company’s operational efficiency but also broadens its potential reach in the global oncology market, including in regions where access to advanced therapies is limited. With the oncology sector experiencing continuous demand for new and effective treatments, TC BioPharm’s unique approach and scalable technology platform offer a promising investment opportunity with the potential for significant returns as the company progresses toward commercialization.

Leadership Team

Bryan Kobel is the Chief Executive Officer of TC BioPharm, having joined the company in June 2021. Before joining TC BioPharm, he held various senior positions in healthcare investment banking, including Managing Director roles at EF Hutton and the Alberleen Group, where he led deal origination and structuring across the healthcare and technology sectors. Mr. Kobel has a BA from Franklin & Marshall College and previously held several FINRA licenses, including Series 7, 63, 82, 79, and 24.

Martin Thorp has been a member of the Board of Directors of TC BioPharm since March 2016 and has served as the company’s Chief Financial Officer since March 2019. He is the founder of Copernican Capital Partners Limited, a life science financial advisory firm, and has an extensive background in corporate finance, having been a partner and global managing partner at Arthur Andersen & Co. Martin holds a BA in business finance from the University of Kent and qualified as a Chartered Accountant in 1977. He served in various executive roles throughout his career, including co-founding NCL Technology Ventures, a life science advisory and investment firm.

Additional Resources

TC BioPharm Holdings PLC (NASDAQ: TCBP), closed Thursday's trading session at $7.5, up 4.6025%, on 230,863 volume. The average volume for the last 3 months is 119,972 and the stock's 52-week low/high is $2.1101/$138.00.

Recent News

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)

The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

CoinGecko has announced that it will hold its first hybrid conference at the iconic ICONSIAM on Nov. 11, 2024, in Bangkok, Thailand. The conference, dubbed GeckoCon: Web3 Games Unleashed, will offer the best of both virtual and physical experiences, catering to a global audience of industry leaders, developers and gaming enthusiasts. This year's GeckoCon is special because of its hybrid format. Historically, the event was held exclusively online to allow everyone around the world to be part of it without the need for traveling. This time, GeckoCon is combining the convenience of virtual attendance with the vibrancy of a physical event. According to Bobby Ong, cofounder and COO of CoinGecko, "At this GeckoCon, we're combining the convenience of virtual access with the energy of an in-person gathering. Participants will enjoy the benefits of both experiences." So, why Thailand? Well, the country was chosen as an ideal place for the conference thanks to its ever-growing interest in cryptocurrency and blockchain technology. Thailand has seen a rapid increase in the adoption of crypto, with various businesses accepting digital currencies and a favorable regulatory environment that encourages innovation. Hosting the event in Thailand represents CoinGecko's commitment to supporting the global expansion of the crypto ecosystem. CoinGecko's first hybrid conference in Thailand is more than just an event; it is a testament to the company's vision of making cryptocurrency data and education accessible to everyone. These conferences could also be an opportunity for companies such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) to get a glimpse into the new technologies that could be useful to the business in the near future.

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Alibaba.com Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Thursday's trading session at $1.23, even for the day, on 37,427 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $138.00/$.

Recent News

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer's ("AD") and Parkinson's disease ("PD"), today announced participation at the H.C. Wainwright 26th Annual Global Investment Conference. The conference, held virtually and in person, is scheduled for September 9-11, 2024, at the Lotte New York Palace Hotel in New York City. According to the announcement, Maria L. Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, will deliver a 30-minute company presentation on Tuesday, September 10, 2024, at 8 a.m. ET. Later that day, at 2 p.m. ET., Dr. Maccecchini will take part in a panel discussion titled "Non-amyloid Approaches in Alzheimer's Disease."

To view the full press release, visit https://ibn.fm/Zdm8R

Annovis Bio Inc. Overview

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as AD and PD. Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach addresses both the cognitive decline in AD and the motor dysfunction in PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly known as Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a 3.3 point improvement compared to 0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating buntanetap’s mechanism of action.

Similarly, in the recently completed Phase III study of buntanetap in patients with early PD, buntanetap significantly improved disease-related daily non-motor and motor functions in Parkinson’s patients who had a diagnosis over 3 years as well as improved cognition in all PD patients. It further underscores buntanetap’s potential as a transformative therapy.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050​ (Alzheimer’s Association)​​ (Republican Policy Committee)​. Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease​ (SingleCare)​.

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050​​. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Recent Phase III data in Parkinson’s Disease patients demonstrates significant improvements in motor and cognitive functions.
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

  • Maria L. Maccecchini, Ph.D. – Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.
  • Cheng Fang, Ph.D. – Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.
  • Michael Christie, Ph.D. – VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.
  • Melissa Gaines – Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.
Recent Achievements

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Investment Considerations
  • Unique Market Position: Annovis Bio is uniquely positioned as the only company developing a drug for both AD and PD that inhibits multiple neurotoxic proteins simultaneously.
  • Strong Clinical Results: Buntanetap’s Phase II/III data shows significant cognitive improvement in early AD patients, and the recent Phase III data in PD patients further validates its broad therapeutic potential.
  • Strategic Growth Plans: With recent successful trial results, Annovis Bio is poised for future growth, supported by strong patent protections and upcoming clinical trials.
  • Significant Market Need: As the prevalence of neurodegenerative diseases continues to rise, the demand for effective treatments like buntanetap remains critical.

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Annovis Bio Inc. (NYSE: ANVS), closed Thursday's trading session at $7.86, off by 6.7616%, on 245,531 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.53/$22.49.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria, a global innovator in drug delivery platforms, has just announced its 4-week and 8-week blood glucose results from its WEIGHT-A24-1 animal study

Two formulations from the study posted outstanding performance, with each utilizing the company's patented DehydraTECH(TM) technology

DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A & B) posted blood sugar level reductions of 2.50%, 1.90%, and 1.53%, respectively

These results build on the positive results from Lexaria's 2023 DIAB-A22-1 animal study, which showed a 16.7% blood sugar concentration increase relative to baseline by day 56 for the obese control group that got no treatment

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its 4-week and 8-week blood glucose results from its WEIGHT-A24-1 animal study (the "study"). This study will examine diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and DehydraTECH-processed cannabidiol, alone and in combination . The ongoing study uses diabetic, pre-conditioned Zucker rats, falling in one of three study arms, with dosing lasting 12 weeks (https://cnw.fm/1u3Rj).

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, effective August 31, 2024. Mr. Christopher is a recognized industry veteran with over three decades of experience in the medical device and pharmaceutical industries. He has domestic and international experience in leadership, operations, acquisitions/licensing, business development, strategic planning and capital markets. Mr. Christopher takes over from outgoing CEO, Chris Bunka, who has stepped aside from the role. Mr. Bunka remains as the Chairman of the Board of Directors and has been appointed Executive Strategic Advisor to the management team.

"I'm delighted that I have been appointed to lead Lexaria," said Mr. Christopher. "The company is well positioned for an exciting period of growth centered around the advancement and improvement of drug delivery in the GLP-1 marketplace. We are preparing for an active and collaborative new era for Lexaria in the pharmaceutical industry."

To view the full press release, visit https://ibn.fm/BMyP2

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Thursday's trading session at $3.3, off by 4.0698%, on 143,548 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.844/$6.85.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

A pilot project with Japan's largest mobile service provider showed that the deployment of D-Wave's annealing quantum computing solutions improved mobile network performance by 15%.

D-Wave's hybrid solver was able to process a task in just 40 seconds, compared to 27 hours with a general-purpose solver.

The project demonstrated a significant reduction in signal congestion across base stations, which can potentially lead to more efficient transmission and cost savings.

This collaboration marks an important step in applying and further integrating quantum computing in telecommunications.

D-Wave Quantum (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, announced the results of a quantum optimization pilot project with Japan's mobile phone operator NTT DOCOMO Inc. ("DOCOMO"), showing demonstrable improvements in mobile network performance (https://ibn.fm/JTeGD).

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Thursday's trading session at $0.9219, off by 0.7428941%, on 1,232,150 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.57/$2.44.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an electric vehicle ("EV") manufacturer, has entered into a partnership agreement with Texas Consulting & Development LLC ("TCD"). According to the agreement, Bollinger will provide TCD with Bollinger B4 Class 4 trucks as part of TCD's new, bundled service offering to ports and other related industries while TCD will leverage the Bollinger B4 to increase sales across an array of sectors, including commercial & industrial, telecom and utility. A U.S.-based company headquartered in Michigan, Bollinger Motors is developing all-electric commercial chassis cab trucks, Classes 4-6; Bollinger Motors became a majority-owned company of Mullen in 2022. TCD provides microgrid and virtual power-plant solutions.

"The partnership provides another opportunity for the Bollinger B4 to help companies from a wide variety of industries electrify their vehicle fleets as TCD helps their clients develop solutions for overall clean-energy strategies," said Bollinger Motors chief revenue officer Jim Connelly in the press release. "TCD is a leader in helping companies reduce their overall carbon footprint, and we're glad that they have chosen to make the B4 an important element of those efforts."

To view the full press release, visit https://ibn.fm/FYBv5

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Thursday's trading session at $0.2159, off by 1.1899%, on 33,768,980 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2012/$75.00.

Recent News

Torr Metals Inc. (TSX.V: TMET)

The QualityStocks Daily Newsletter would like to spotlightFathom Torr Metals Inc. (TSX.V: TMET) .

Torr Metals (TSX.V: TMET), a mineral exploration company dedicated to advancing its wholly owned, district-scale copper-gold porphyry and orogenic gold projects in highly accessible mining regions of Canada, is the focus of the latest episode of The MiningNewsWire Podcast. According to the announcement, Torr Metals president, CEO and director Malcolm Dorsey is a featured guest on the most recent episode of the podcast, which features interviews with executives who are shaping the future of the global mining industry. During the episode, Dorsey and podcast host Stuart Smith discuss the company and its vision.

In addition, Torr Metals is featured in a NetworkNewsAudio ("NNA") broadcast covering the latest final assay results released by the company from rock grab samples collected during this year's reconnaissance programs at the Kolos Copper-Gold Project. The results indicate additional high-grade rock grab assays within the Kirby, Rea and Clapperton exploration target zones; they also show a new copper-gold discovery in the northern portion of the Kolos Copper-Gold Project, which is called the Sonic Zone. NNA is a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points.

To listen to the podcast, visit https://ibn.fm/Nxquc

To listen to the audio production, visit https://ibn.fm/Xf2q5

To view the full press releases, visit https://ibn.fm/pJrfv and https://ibn.fm/bvMd0

Torr Metals Inc. (TSX.V: TMET) operates as a mineral exploration company focusing on the identification, acquisition, and advancement of mineral properties. With full 100% ownership of over 1,000 square kilometers of gold and copper projects strategically positioned in premier low-cost mining jurisdictions, Torr is poised for substantial returns across various promising regions.

The company’s extensive portfolio encompasses multiple district-scale projects, including the Filion Gold Project in northern Ontario, the Kolos Copper-Gold Project in south-central British Columbia, and the Latham Copper-Gold Project in northern British Columbia. These projects are all located in prolific mining regions with paved highway access, robust support infrastructure, and favorable geological conditions offering significant potential for new discoveries.

Headquartered in Vancouver, British Columbia, Torr Metals is ideally situated to leverage its expertise and resources for continued exploration and growth.

Projects

Kolos Copper-Gold Project

Situated within British Columbia’s prime copper-producing belt, the 140-square-kilometer Kolos Copper-Gold Project exhibits Nicola Belt geology similar to notable porphyry mines, including Copper Mountain and Highland Valley, respectively situated 106 kilometers to the south and 30 kilometers to the northwest.

With field operations based in the nearby city of Merritt and year-round access provided via Highway 5, the Kolos Project showcases substantial discovery upside potential with five defined large-scale copper-gold-molybdenum anomalies untested by drilling.

Torr Metals’ primary focus lies in unlocking the potential for major new discoveries at the Kolos Copper-Gold Project, with recent surface geochemical results marking a significant milestone positioning the company as a new key player in the region.

Filion Gold Project

The 261-square-kilometer Filion Project is situated within a largely unexplored greenstone belt where gold was initially discovered in the 1930s. With a comparable geological setting to regional orogenic gold deposits and multiple newly identified and undrilled gold trends in surficial geochemistry, the Filion Project holds significant district-scale exploration promise.

The Filion Project benefits from unparalleled infrastructure access, with direct drive-on access from the Trans-Canada Highway, as well as a regional railway and power grid four kilometers to the south. Additionally, the nearby town of Kapuskasing, with a population of 8,300, provides essential support services.

This strategic positioning ensures the Filion Project’s viability for cost-effective, year-round operations in an area poised for untapped discovery potential.

Latham Copper-Gold Project

Situated in British Columbia’s renowned Golden Triangle, the Latham Project spans a vast 689-square-kilometer district, offering immense potential for multiple major discoveries. Accessible year-round via Highway 37, just 20 kilometers south of the town of Dease Lake, the site is strategically located amidst established mining infrastructure, including the active Red Chris mine to the southeast and upcoming major porphyry projects at Schaft Creek and Galore Creek along-trend to the southwest.

Highlighted by the Gnat Pass copper-gold porphyry deposit dating back to the 1960s, the Latham Project presents a compelling opportunity for significant expansion and potential discovery. A non-compliant indicated resource at the Gnat Pass deposit includes 33 million tonnes at 0.39% copper, open beyond 200 meters vertical depth, alongside six drill-ready kilometer-scale copper-gold exploration targets.

Moreover, the Latham Project’s appeal corresponds to the region being an attractive destination for major asset acquisitions and takeovers. Recent transactions within a 40-kilometer radius include Newmont’s 2021 acquisition of the Saddle North copper-gold porphyry deposit for $311 million and Newcrest’s investment in the Red Chris copper-gold porphyry deposit in 2019 for $804 million, underscoring industry acknowledgment of the region’s potential.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 that the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Likewise, a report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Malcolm Dorsey, P.Geo., is President, CEO and Director of Torr Metals. He brings over a decade of expertise as a seasoned exploration geologist and project developer, having been pivotal in driving the success of numerous diverse projects across North, Central, and South America. His comprehensive background spans early-stage exploration through to resource development and project acquisitions. His academic credentials include an M.Sc. in Geology and Geophysics from the University of Calgary, where his research characterized the district-scale structural influences affecting copper and gold mineralizing events in western British Columbia. Prior to his current role, he served as Senior Geologist for Benchmark Metals, where his contributions were instrumental in advancing the company’s gold equivalent resource from approximately 80,000 ounces to a maiden resource estimate of 2.92 million ounces.

John Williamson, P. Geol., is Chairman and Director of Torr Metals. He is a mining executive and investor with more than 30 years of experience as a founder, promoter and leader in the formation, financing and operation of private and public companies with exploration and mining interests worldwide. On more than one occasion his team’s efforts have been recognized for excellence by being named to the TSX Venture 50. He holds a B.Sc. in Geology and is a registered Professional Geologist (P.Geol.) with the Association of Professional Engineers and Geoscientists (APEGA) and the Geological Association of Canada.

Torr Metals Inc. (TSX.V: TMET), closed Thursday's trading session at $27.13, up 0.4071058%, on 63 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $24.01/$31.90.

Recent News

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF)

The QualityStocks Daily Newsletter would like to spotlight Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF).

SASB gas field is producing critical domestic supply of natural gas during Europe's current energy crisis.

With all perforations now complete, West Akcakoca-1 is producing 2.8 MMcf/d using a 28/64 choke to ensure its high pressure will not back out other wells.

The next program phase aims to end this year with five development wells and one stratigraphic well, for a total of six producing wells.

Trillion Energy International (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye, has perforated all remaining gas pay in the SASB wells and has provided an update on production levels.

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF), along with its consolidated subsidiaries, is a Canadian oil and gas exploration and production company with operations primarily focused in the Republic of Türkiye.

Headquartered in Canada, the company owns 49% of the SASB natural gas field, which is producing critical domestic supply of natural gas during Europe’s ongoing energy shortages. It also holds a 19.6% (except three wells with 9.8%) ownership interest in the Cendere Oil Field and has a farm-in agreement to earn 50% interest in three oil exploration blocks in southeast Türkiye called Cudi-Gabar.

Trillion Energy utilizes state-of-the-art technology and ingenious practices to produce and distribute oil and natural gas while still maintaining a commitment to sustainable and responsible operations. Whether through the development of new projects or optimizing existing assets, the company continues to seek new and innovative ways to drive growth and value for its stakeholders.

Headquartered in Vancouver, British Columbia, Trillion Energy is led by seasoned professionals who collectively boast over a century of energy exploration and development experience.

Projects

SASB Gas Field

The SASB Gas Field is producing and delivering critical domestic supplies of natural gas as energy shortages grip Europe due to Russia’s invasion of Ukraine.

Located in the southwestern Black Sea, the SASB gas field consists of numerous conventional natural gas pools located in shallow water. The fields have produced over 43 billion cubic feet (BCF) since initial development in 2007 and continue to provide much needed energy to Türkiye and the EU. Total infrastructure to date, including production platforms, pipelines, initial wells and gas processing plant, cost in excess of $600 million.

Trillion Energy is redeveloping the field with a strategic planned program of approximately 17 wells which commenced in 2022. Phase B of the program, targeted for 2024/25, consists of the re-entry of five legacy wells to drill sidetrack development wells and one exploration stratigraphic well.

Cendere Oil Field

Trillion Energy’s Cendere oil field is a long-term, low decline, stable oil production field located in Türkiye. The company has a 19.6% interest in the field, except for three wells in which its interest is 9.8%.

Cash flow after operating costs from the field is $120,000 to $140,000 per month, with average current production netting the company 110-120 barrels of oil per day. Estimated remaining Cendere oil reserves total 1.5 million barrels (0.277 million barrels net Trillion Energy).

The gross value of Trillion Energy’s interest is estimated at $13.85 million (NPV10).

Cudi-Gabar

Trillion Energy’s 10-well oil exploration drilling program is occurring on three prospective oil blocks located in the prolific Cudi-Gabar oil province in southeast Türkiye. The total area of the three blocks is 374,325 acres.

Trillion Energy’s potential 50% working and revenue interest in the blocks is earned by paying 100% of the work program costs. The company will operate the exploration program.
During 2023/24, Trillion Energy will shoot 351 kilometers of 2D seismic (150 km already shot on the eastern block) and drill four wells. The remaining six wells will be paid 50% by Trillion and 50% by the company’s partner. The oil blocks are surrounded by more than 10 major oil discoveries, half of which are recent.

Market Opportunity

A January 2024 report by Emergen Research, a market research and consulting company, estimated the global natural gas market at $310.5 trillion in 2022 and projected the market will be worth $443.8 trillion by 2032, achieving a CAGR of 3.7% during the forecast period. Increasing global economic activity and rising electricity consumption are key factors driving revenue growth of the market, according to the report.

Trillion Energy reports strong demand for natural gas in Türkiye, which is the seventh-largest natural gas consuming country in the world. Türkiye currently imports 98% of the natural gas it consumes, with about 60% of those imports coming from Iran and Russia.

Management Team

Dr. Arthur Halleran is CEO and Director of Trillion Energy. He has a Ph.D. in Geology from the University of Calgary and 44 years of petroleum exploration and development experience. His international experience includes work in Canada, Colombia, Egypt, India, Guinea, Sierra Leone, Sudan, Suriname, Chile, Brazil, Bulgaria, Türkiye, Pakistan, Peru, Tunisia, Trinidad Tobago, Argentina, Ecuador and Guyana. Dr. Halleran has worked for Petro-Canada, Chevron, Rally Energy and United Hydrocarbon International Corp. In 2007, he founded Canacol Energy Ltd., now the largest natural gas producer in Colombia.

Al Thorsen is COO of Trillion Energy. He is responsible for production operations of the SASB gas field, as well as future drilling activities in Türkiye and abroad. Highlights of his career include Valeura Energy Inc. as operations manager in Türkiye; Journey Energy, leading a production team; Rio Alto Exploration as country manager and production manager; Zargon Oil and Gas as VP of Operations; Orleans Energy as VP of Operations; and Central Petroleum as COO. He holds a Bachelor of Science in Petroleum Engineering from Montana College of Mineral Science & Technology.

Trillion Energy International Inc. (OTCQB: TRLEF), closed Thursday's trading session at $0.09, off by 9.7292%, on 83,492 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0682/$1.15.

Recent News

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF)

The QualityStocks Daily Newsletter would like to spotlight Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF).

Annovis Bio Inc. Overview

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly owned multi-commodity mineral properties in Canada. The company owns the Parbec gold deposit on the Cadillac Break in Quebec and is currently exploring the Parbec property to increase the gold resource and identify a location to strip and bulk sample from surface.

In addition, the company holds the Nixon Bartleman gold property in Ontario and is also engaged in developing its wholly owned Malartic Metals Package, Quebec’s newest polymetallic battery minerals district with several areas of mineralization, one of which is the nickel, cobalt, copper and zinc mineralized Victoria structure boasting approximately 20 kilometers of strike with surface mineralization, limited drilling, road access and hydroelectric power.

Renforth is well positioned in the heart of the Abitibi Greenstone belt, which straddles the Canadian Provinces of Ontario and Quebec, on both of the Cadillac-Larder Lake and Destor-Porcupine faults – the two main structures responsible for a belt endowed with more than 300 million ounces of gold (including production, M&I reserves and resources to date), making it one of the world’s most prospective gold regions.

The Canadian Malartic Mine, one of Canada’s largest gold mines, is adjacent to each of Renforth’s brownfield Malartic area properties, the Parbec open pit gold resource and the Malartic Metals Package, which, in addition to several known battery metals mineralized structures, also hosts gold within the Pontiac sediments, a very under-explored geological setting.

The company is headquartered in Pickering, Ontario.

Projects

Parbec Gold Deposit

Renforth’s 100% owned Parbec Gold Deposit contains a gold resource designed with an open pit to capitalize on Parbec’s surface mineralization. An MRE on the project, effective December 2019 and now considered by Renforth to be obsolete, is based upon approximately 28,000 meters of drilling which occurred between 2007 and 2019.

Renforth drilled 15,000 meters of new holes in 2020 and 2021 which were not included in the MRE, but which did extend the mineralization deeper within the MRE. The 2020-21 drilling is considered to have validated an additional 13,000 meters of historic drilling from 1986-93.

The validation occurs as 10% of the historic holes were redrilled, with results comparable to the historic results in terms of geology and gold values. Any future MRE calculated at Parbec will benefit from the inclusion of the new and historic drilling.

In addition to this, Renforth’s current structural interpretation on the location of, and controls on, the gold mineralization at Parbec is materially different than the geological model for the outdated MRE. For the first time, Renforth has mapped the Pontiac contact and interpreted a hinge fold interacting with the Cadillac Break and allowing the movement of gold enriched fluids, with mineralization plunging to the south, into the Pontiac.

It is worth noting that a structural control on the adjacent, and much larger, Canadian Malartic Mine is the Sladen Fault transiting into the Pontiac. Currently, Renforth is testing this interpretation with a soil survey designed to outline an area for stripping and bulk sampling within the Pontiac south of the Cadillac Break.

Malartic Metals Package

Renforth’s wholly owned approximately 300-square-kilometer Malartic Metals Package in Quebec’s mining heartland includes surface mineralization of battery metals nickel, cobalt, copper, zinc and silver in separate structures, as well as a copper/silver discovery and gold mineralization. Lithium is also present in anomalous amounts in the sediments, though the source has not yet been located.

The property was assembled commencing in 2020 by adding claims to Renforth’s existing Malartic West property by map staking. The goal was to acquire historic gold and base metal showings, as well as pronounced magnetic anomalies, joining several of the areas of discrete historic exploration into a district scale property with several areas of interest for battery metals and a greenfield copper/silver discovery. The property benefits from its location in an established mining community, roads on the property, rail just off the property and hydroelectric power lines crossing the property, making logistics simple and the cost to operate quite low.

This is the first time this property has been assembled as it is today and actively explored. A significant portion of the property has never been explored.

Market Overview

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In August 2024, the market price of gold was approximately $2,435 per ounce.

Management Team

Nicole Brewster is President and CEO of Renforth Resources. During her tenure she has reconstituted the company, developed a maiden mineral resource and sold a gold deposit. She is a native of the Toronto area and has been around the mining business nearly all her life, having been raised by a successful mineral exploration geologist who worked (and is still working) around the world as an entrepreneur and geoscientist.

Ms. Brewster worked summer jobs in various segments of the mining business, which led to her employment as a contractor working in the early days of the digitization of exploration data, 3D modeling and data visualization. After working in the capital markets for a time, she returned to the mineral exploration business as a partner in a successful private firm with several employees.

Renforth Resources Inc. (OTCQB: RFHRF), closed Thursday's trading session at $0.012, up 17.2447%, on 10,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0068/$0.0278.

Recent News

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)

The QualityStocks Daily Newsletter would like to spotlight Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF).

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) is an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. The Project has a 2011 historical mineral resource estimate of 727,000 ounces of Au at 5.42 g/t and an average thickness of 5.71 m*.

In 2023, with the use of AI (Artificial Intelligence), Emperor Metals created the first ever 3D mineralized and geological model, which illuminated the potential to add significant ounces to this deposit. Using these models, Emperor’s had a very successful 2023 drilling campaign of 8,579 m. In addition to laterally extending high grade zones by intercepting grades of 15.8 g/t Au over 10.8 meters, Emperor encountered intercepts of lower grade bulk tonnage in the host rocks (1.69 g/t Au over 25 m). This led to envisioning a different strategy of exploration and the revelation that a conceptual open-pit potentially overlies this high-grade gold deposit. Historic core sampling began (2,500 m) for discovering overlooked lower grade gold in the host rock around the high-grade lenses. Lower grade bulk tonnage gold improves the open-pit economics by reducing stripping ratios and adding overlooked incremental ounces for open pit mining.

Emperor Metals is set to begin a fully funded Phase II 8,000 m drilling program in May 2024. The company also plans on assaying an additional 8,000 m of historic core within the open pit model. Emperor is working toward producing an updated NI 43-101 Mineral Resource Estimate by Q1 2025.

The company is led by a dynamic group of resource sector professionals who have a strong record of success in evaluating and advancing mining projects from exploration through to production, attracting capital and overcoming adversity to deliver exceptional shareholder value.

Project

Emperor Metals has an option to earn 100% ownership of the Duquesne West Gold Project, a mineral claim package comprising 38 claims covering approximately 1,389 ha (3,432 acres) in Quebec.

The Duquesne West Gold Property is located 32 kilometers northwest of the city of Rouyn-Noranda and 10 kilometers east of the town of Duparquet. The property lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt in the Superior Province.

Emperor is targeting the potential multimillion-ounce resource in a combination of conceptual open pit and underground mining scenarios. A Phase I drill campaign and historical core sampling program was completed in 2023, which included resource confirmation and exploration drilling, focusing on delineating and growing the resource toward development.

The property hosts a historical inferred mineral resource estimate of 727,000 ounces of gold at a grade of 5.42 grams per ton (g/t) and average stope thickness of 5.71 m. The mineral resource estimate predates modern Canadian Institute of Mining guidelines, and a Qualified Person on behalf of Emperor Metals has not reviewed or verified the mineral resource estimate. Therefore, it is considered historical in nature and is reported solely to provide an indication of the magnitude of mineralization that could be present on the property. The gold system remains open for resource identification and expansion.

Reinterpretation of the existing geological model was created using artificial intelligence and machine learning. This AI model shows the opportunity for additional discovery of ounces by revealing gold trends unknown to previous workers and the potential to expand the resource along significant gold-endowed structural zones. Multiple scenarios exist to expand additional resources, which include:

  • Underground High-Grade Gold
  • Open Pit Bulk Tonnage Gold
  • Underground Bulk Tonnage Gold

The Duquesne West-Ottoman property straddles the Porcupine-Destor gold localizing fault several kilometers east of the town of Duparquet. A number of previous drill campaigns have outlined an inferred resource of 4.17 million tons grading 5.42 g/t of gold (cut) or 6.36 g/t (uncut), as reported in the NI 43-101 report titled “Technical Report and Mineral Resource Estimate Update for the Duquesne-Ottoman Property, Quebec, Canada.”

Emperor Metals is funded for an 8,000-meter drilling program focusing primarily on adding ounces to the current resource within and lateral to the open pit model. An additional 8,000 m of historical core sampling and assaying is included in the budget to help build incremental ounces in the open-pit environment.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, to be worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

In May 2024, the market price of gold was approximately $2,340 per ounce.

Management Team

John Florek, P.Geol., is President, CEO and Director of Emperor Metals. He has more than 35 years of technical and senior management experience with major and junior mining companies, including roles as founder, vice president and director. He has helped identify and develop significant asset value for mines and exploration projects from grass roots through development. He has worked for several major mineral producers, including BHP, Placer Dome, Barrick, Teck and Detour Gold/Kirkland Lake Gold/Agnico Eagle.

Sean Mager is CFO and Director of Emperor Metals. He has worked more than 30 years in the mining sector, including extensive experience in corporate development, stakeholder relations, regulatory, financial and operations.

Alex Horsley is Head of Corporate Development and Director of Emperor Metals. He has more than 20 years of experience in the mining sector and capital markets with a focus on finance, marketing, management, corporate development and communications. He is founder and former CEO of Emperor Metals. He has assisted in raising more than C$40 million for exploration and development mining companies.

*Power-Fardy and Breede, 2011. The Mineral Resource Estimate (MRE) constructed in 2011 is considered historical in nature as it was constructed prior to the most recent Canadian Institute of Mining and Metallurgy (CIM) standards (2014) and guidelines (2019) for mineral resources. In addition, the economic factors used to demonstrate reasonable prospects of eventual economic extraction for the MRE have changed since 2011. A qualified person has not done sufficient work to consider the MRE as current. Emperor is not treating the historical MRE as current. The reader is cautioned not to treat it, or any part of it, as a current MRE.

Emperor Metals Inc. (OTCQB: EMAUF), closed Thursday's trading session at $0.066, up 10%, on 18,160 volume. The average volume for the last 3 months is 73,822 and the stock's 52-week low/high is $0.058/$0.14505.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Thursday's trading session at $0.017, up 13.3333%, on 5,643 volume. The average volume for the last 3 months is 13,872 and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Thursday's trading session at $0.03745, even for the day, on 3,000 volume. The average volume for the last 3 months is 20,318 and the stock's 52-week low/high is $0.03/$0.2269.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.